miRNA-29a in systemic sclerosis: A valid target
- 14 August 2015
- journal article
- editorial
- Published by Taylor & Francis in Autoimmunity
- Vol. 48 (8) , 511-512
Abstract
Systemic sclerosis is an autoimmune disease that contains an interplay between inflammation and fibrosis. The ultimate effector cell is the myofibroblast that secretes excessive matrix molecules leading to fibrosis. There is no treatment that modifies the disease and this is an unmet clinical need. In this issue of Autoimmunity, Jafarinejad-Farsaangi et al., demonstrate that restitution of microRNA-29a targets the apoptosis rheostat and leads to apoptosis in dermal fibroblasts, suggesting that in vivo targeting of the microRNA through mimics would lead to depletion of the fibroblasts.Keywords
This publication has 9 references indexed in Scilit:
- MicroRNA29a regulates IL-33-mediated tissue remodelling in tendon diseaseNature Communications, 2015
- MicroRNA-29a induces apoptosis via increasing the Bax:Bcl-2 ratio in dermal fibroblasts of patients with systemic sclerosisAutoimmunity, 2015
- MiR-29a Reduces TIMP-1 Production by Dermal Fibroblasts via Targeting TGF-β Activated Kinase 1 Binding Protein 1, Implications for Systemic SclerosisPLOS ONE, 2014
- Tumor necrosis factor–costimulated T lymphocytes from patients with systemic sclerosis trigger collagen production in fibroblastsArthritis & Rheumatism, 2012
- miR-29 Inhibits Bleomycin-induced Pulmonary Fibrosis in MiceMolecular Therapy, 2012
- Effects of Microrna-29 on Apoptosis, Tumorigenicity, and Prognosis of Hepatocellular CarcinomaHepatology, 2009
- mir-29 regulates Mcl-1 protein expression and apoptosisOncogene, 2007
- Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane‐associated tumor necrosis factor αArthritis & Rheumatism, 2003
- Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis.Journal of Clinical Investigation, 1995